167 related articles for article (PubMed ID: 68808)
1. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
[No Abstract] [Full Text] [Related]
2. Humoral immunologic response in patients with tumors of the breast.
Glazman H; Salwa J; Harlozińska A
Arch Immunol Ther Exp (Warsz); 1973; 21(1):175-84. PubMed ID: 4720430
[No Abstract] [Full Text] [Related]
3. Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
Franchimont P; Zangerle PF; Nogarede J; Bury J; Molter F; Reuter A; Hendrick JC; Collette J
Cancer; 1976 Dec; 38(6):2287-95. PubMed ID: 63315
[TBL] [Abstract][Full Text] [Related]
4. Isoantigens A, B and H in benign and malignant lesions of breast.
Gupta RK; Schuster R
Am J Pathol; 1973 Aug; 72(2):253-7. PubMed ID: 4807589
[TBL] [Abstract][Full Text] [Related]
5. Casein and other tumor markers in relation to cancer of the breast.
Zangerle PF; Thirion A; Hendrick JC; Franchimont P
Antibiot Chemother (1971); 1978; 22():141-8. PubMed ID: 74972
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
Wittekind C; von Kleist S; Sandritter W
Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
[TBL] [Abstract][Full Text] [Related]
7. Serum antibody in patients with mammary disease.
Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ
Cancer; 1974 Oct; 34(4 Suppl):suppl:1516-20. PubMed ID: 4214083
[No Abstract] [Full Text] [Related]
8. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
[No Abstract] [Full Text] [Related]
9. [Tumor markers. Current knowledge and practical usefulness].
Papaleo G; Sacerdoti G; Zito GA
Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719
[No Abstract] [Full Text] [Related]
10. Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast.
Avis F; Avis I; Newsome JF; Haughton G
J Natl Cancer Inst; 1976 Jan; 56(1):17-25. PubMed ID: 1255745
[TBL] [Abstract][Full Text] [Related]
11. [Relevance of CEA in benign breast disease (author's transl)].
Opri F; Kirchner H; Mayfeld K
Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):51-4. PubMed ID: 7353775
[TBL] [Abstract][Full Text] [Related]
12. Immunologic aspects of cancer of the breast.
Marcus DM
Am J Clin Pathol; 1975 Dec; 64(6):786-91. PubMed ID: 53999
[No Abstract] [Full Text] [Related]
13. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
Wagener C; Breuer H
J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
[No Abstract] [Full Text] [Related]
14. Simultaneous measurements of tumour-associated antigens in gastrointestinal cancer.
Go VL
Clin Gastroenterol; 1976 Sep; 5(3):645-51. PubMed ID: 66112
[No Abstract] [Full Text] [Related]
15. CEA and NCA in benign and malignant breast tumors.
Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
[TBL] [Abstract][Full Text] [Related]
16. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
17. Serum oestradiol-17 beta in women with benign and malignant breast disease.
England PC; Skinner LG; Cottrell KM; Sellwood RA
Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
19. [Course studies by means of tumor markers].
Quentmeier A
Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606
[No Abstract] [Full Text] [Related]
20. [Diagnosis of malignant diseases using tumor markers].
Schneider J
Biomed Tech (Berl); 1984 Nov; 29(11):278-82. PubMed ID: 6210115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
